China’s Ministry of Finance has introduced new procurement restrictions targeting medical devices imported from the European Union (EU) in government projects exceeding 45 million CNY (~5.34 million EUR). These measures exclude EU enterprises—except EU-funded firms based in China—from participation in such procurements and limit non-EU companies’ EU-imported device share to no more than 50% of contract value.
The restrictions respond to the EU’s June 2025 ban on Chinese medical device companies in government purchases over 5 million EUR. China’s government stressed it had sought dialogue with the EU to resolve disputes but is compelled to enact reciprocal measures to protect Chinese businesses and ensure fair competition.
Exceptions apply when only EU imports can fulfill procurement needs, and contracts awarded before July 6, 2025, are unaffected.
Follow MEDWIRE.AI for updates on global medical device trade and regulatory developments.
